Thrombin activatable fibrinolysis inhibitor activation peptide shows association with all major subtypes of ischemic stroke and with TAFI gene variation.
about
Where will the next generation of stroke treatments come from?Association between polymorphisms in the flanking region of the TAFI gene and atherosclerotic cerebral infarction in a Chinese populationSex-specific effect of CPB2 Ala147Thr but not Thr325Ile variants on the risk of venous thrombosis: A comprehensive meta-analysisPlasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular eventsAmbivalent roles of carboxypeptidase B in the lytic susceptibility of fibrin.Genome scan of clot lysis time and its association with thrombosis in a protein C-deficient kindred.The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis ProfileA genome-wide exploration suggests an oligogenic model of inheritance for the TAFI activity and its antigen levelsGenetic aspects of ischemic stroke: coagulation, homocysteine, and lipoprotein metabolism as potential risk factors.Insights into thrombin activatable fibrinolysis inhibitor function and regulation.What causes intracerebral bleeding after thrombolysis for acute ischaemic stroke? Recent insights into mechanisms and potential biomarkers.Dose-Response Relationship Between Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) and Stroke: A Chinese Case-Control Study.Convalescent plasma levels of TAFI activation peptide predict death and recurrent vascular events in ischemic stroke survivors.TAFI gene polymorphisms in patients with cerebral venous thrombosis.Short-term effect of infliximab is reflected in the clot lysis profile of patients with inflammatory bowel disease: a prospective study.
P2860
Q30979218-36A0D97C-F4E4-4474-87EF-BEBA13B3F57AQ33631692-1685BB86-6091-4B01-8BD4-E27AC9ADB33CQ33731941-8FC88C86-27D3-475A-A77E-92BA96C070CBQ34159230-B50AA327-EBC1-47A7-B66C-BECEB127283FQ35008316-258782A6-2F41-4BF7-B714-C249AD137049Q35111799-F3292B57-0297-459C-B1B0-BC747756A6B8Q36217509-D5F088AB-1E35-4B48-B817-485D24C1ACD6Q36992117-823E2CA9-ECD0-4B0B-AEE4-75D90088F372Q37768794-DC7BB2EC-93AA-4A10-89AB-2FE731957C59Q38117742-86AA6DF1-8947-41DA-AFF8-FEE763B471F6Q38392999-FC51A023-326F-43BB-8A6F-6B9B63CF3DD9Q40048594-CCDF7CAC-9EAF-419E-8DAD-DD25937154CCQ44739646-5B0EC0BC-23E4-4BD0-8EA4-157707CB363BQ53127456-BFB8D310-3C67-404B-B5FF-7FE03F1A1441Q53617328-1603C5AE-B108-4C31-8001-B39CD7400F78
P2860
Thrombin activatable fibrinolysis inhibitor activation peptide shows association with all major subtypes of ischemic stroke and with TAFI gene variation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Thrombin activatable fibrinoly ...... and with TAFI gene variation.
@en
Thrombin activatable fibrinoly ...... and with TAFI gene variation.
@nl
type
label
Thrombin activatable fibrinoly ...... and with TAFI gene variation.
@en
Thrombin activatable fibrinoly ...... and with TAFI gene variation.
@nl
prefLabel
Thrombin activatable fibrinoly ...... and with TAFI gene variation.
@en
Thrombin activatable fibrinoly ...... and with TAFI gene variation.
@nl
P2093
P1476
Thrombin activatable fibrinoly ...... and with TAFI gene variation.
@en
P2093
Christina Jern
Claes Ladenvall
Katarina Jood
P304
P356
10.1161/01.ATV.0000259354.93789.A6
P407
P577
2007-02-01T00:00:00Z